Pfizer Beats Q4 Estimates, Eyes Growth Beyond Covid Products
Pfizer (PFE) reported fourth-quarter earnings on Tuesday that surpassed analyst expectations, driven by higher-than-expected demand for its Covid products and ongoing cost-cutting efforts. Q4 Earnings Highlights Despite the earnings beat, Pfizer stock